Nurix Therapeutics, Inc.
NRIX$808M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBRISBANE286 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 8, 2026
19dMarket Overview
Stock performance and key metrics
NRIX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NX-5948 | Phase 2 | Chronic Lymphocytic Leukemia (CLL) | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply